Phentermine And Topiramate
A Study Comparing Multiple Doses of VI-0521 With Placebo and Their Single-agent Constituents for Treatment of Obesity in Adults
VIVUS · Phase 3 · Completed · Enrollment 756
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| VI-0521 Top | Obesity or overweight | n/r | 28 | n/r | n/r |
| VI-0521 Mid | Obesity or overweight | n/r | 28 | n/r | n/r |
| TPM 46 | Obesity or overweight | n/r | 28 | n/r | n/r |
| TPM 92 | Obesity or overweight | n/r | 28 | n/r | n/r |
| PHEN 7.5 | Obesity or overweight | n/r | 28 | n/r | n/r |
| PHEN 15 | Obesity or overweight | n/r | 28 | n/r | n/r |
| Placebo | Obesity or overweight | n/r | 28 | n/r | n/r |